National Bank Of Canada Bio Xcel Therapeutics, Inc. Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 1,020 shares of BTAI stock, worth $2,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,020
Previous 2,375
57.05%
Holding current value
$2,356
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BTAI
# of Institutions
51Shares Held
8.69MCall Options Held
22.2KPut Options Held
27.7K-
Armistice Capital, LLC New York, NY4.32MShares$9.97 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$2.95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$2.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$720,6390.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $64.7M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...